ロード中...
Syngeneic B16-F1 cells are more efficient than allogeneic Cloudman cells as antigen source in DC-based vaccination in the B16-F1 murine melanoma model
A major obstacle to obtaining relevant results in cancer vaccination has been the lack of identification of immunogenic antigens. Dendritic cell (DC)-based cancer vaccines used preventively may afford protection against tumor inoculation, but the effect of antigen choice on anti-tumor protection is...
保存先:
| 出版年: | Vaccine |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7713901/ https://ncbi.nlm.nih.gov/pubmed/31307876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2019.07.018 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|